logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
B

Bülent Yalçın

ankara bilkent city hospital

24H指数
296论文数
3.0K被引数
收录论文 38
发表时间
logo
Prognostic value of the glucose-to-lymphocyte ratio in surgically treated endometrial cancer: a retrospective cohort study
errFuture Oncology
IF2.6
err2026-01-28
err0
PREAI
errFurkan Ceylan; Serhat Sekmek; Ateş Kutay Tenekeci; Safa Can Efil; Sena Kaya Ceylan; Efnan Algın; M.Bülent Akıncı; Fahriye Tuba Köş; Didem Şener Dede; Burak Civelek; Mehmet Ali Nahit Şendur; Bülent Yalçın
err分享
err收藏
Synergistic prognostic effect of the renin-angiotensin-aldosterone system and immune-checkpoint inhibition in advanced lung cancer: The SPERICIL study肾素-血管紧张素-醛固酮系统与免疫检查点抑制在晚期肺癌中的协同预后效应：SPERICIL研究
errINTERNATIONAL JOURNAL OF CANCER
IF4.7
err2025-10-01
err0
PREAI
errEfil, Safa Can; Celebi, Sema Nur Ozsan; Ozturk, Beste; Bilgin, Burak; Hizal, Mutlu; Yucel, Sebnem; Akinci, Muhammed Bulent; Dede, Didem Sener; Yalcin, Bulent; Sendur, Mehmet Ali Nahit
err分享
err收藏
Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+HER2-Negative Metastatic Breast Cancer
errJOURNAL OF CLINICAL MEDICINE
IF2.9
err2024-12-31
err0
errOAAI
errCeylan, Furkan; Mehdiyev, Mirmehdi; Dede, Didem Sener; Efil, Safa Can; Tenekeci, Ates Kutay; Bilgin, Burak; Yucel, Sebnem; Dogan, Hayriye Tatli; Sendur, Mehmet Ali Nahit; Akinci, Muhammed Bulent; Uncu, Dogan; Yalcin, Buelent
err分享
err收藏
What is the ideal treatment for advanced non-small-cell lung cancer with PD-L1 level ≥50%? Is mono immunotherapy enough?
errFUTURE ONCOLOGY
IF2.6
err2024-11-25
err0
PREAI
errBilgin, Burak; Yucel, Sebnem; Sendur, Mehmet Ali Nahit; Yalcin, Bulent
err分享
err收藏
Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment
errSCIENTIFIC REPORTS
IF3.9
err2024-05-09
err0
errOAAI
errBardakci, Murat; Karakas, Hilal; Bayram, Dogan; Avci, Nilufer; Kitapli, Sait; Ozen, Mirac; Aslan, Ferit; Koseoglu, Caglar; Kadioglu, Ahmet; Onur, Ilknur D.; Sakalar, Teoman; Buyuksimsek, Mahmut; Alkan, Ali; Ergun, Yakup; Kaya, Ali O.; Bilgin, Burak; Yalcin, Bulent
err分享
err收藏
The diurnal change of thyroid-stimulating hormone and the effect of this change on thyroid functions in patients with chronic kidney disease
errENDOCRINE
IF2.9
err2023-07-25
err1
PREAI
errSoylu, Hueseyin; Ersoy, Reyhan; Keske, Pelin Bal; Tuncay, Merve Ergin; Ates, Can; cakir, Bekir; Yalcin, Buelent
err分享
err收藏
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer瑞博西尼或帕博西尼联合来曲唑治疗激素受体阳性/HER2-negative转移性乳腺癌的疗效
errFUTURE ONCOLOGY
IF2.6
err2023-05-03
err10
PREAI
errKahraman, Seda; Erul, Enes; Seyyar, Mustafa; Gumusay, Ozge; Bayram, Ertugrul; Demirel, Burcin Cakan; Acar, Omer; Aksoy, Sercan; Baytemur, Naziyet Kose; Sahin, Elif; Cabuk, Devrim; Basaran, Gul; Paydas, Semra; Yaren, Arzu; Guven, Deniz Can; Erdogan, Atike Pinar; Demirci, Umut; Yasar, Alper; Bayoglu, Ibrahim Vedat; Hizal, Mutlu; Gulbagci, Burcu; Paksoy, Nail; Davarci, Sena Ece; Yilmaz, Funda; Dogan, Ozlem; Orhan, Sibel Oyucu; Kayikcioglu, Erkan; Aytac, Ali; Keskinkilic, Merve; Mocan, Eda Eylemer; Unal, Olcun Umit; Aydin, Esra; Yucel, Hakan; Isik, Deniz; Eren, Onder; Uluc, Basak Oyan; Ozcelik, Melike; Hacibekiroglu, Ilhan; Aydiner, Adnan; Demir, Hacer; Oksuzoglu, Berna; Cilbir, Ebru; Cubukcu, Erdem; Cetin, Bulent; Oktay, Esin; Erol, Cihan; Okutur, Sadi Kerem; Yildirim, Nilgun; Alkan, Ali; Selcukbiricik, Fatih; Aksoy, Asude; Karakas, Yusuf; Ozkanli, Gulhan; Duman, Berna Bozkurt; Aydin, Dincer; Dulgar, Ozgecan; Er, Muhammed Muhiddin; Teker, Fatih; Yavuzsen, Tugba; Aykan, Musa Baris; Inal, Ali; Iriagac, Yakup; Kalkan, Nurhan Onal; Keser, Murat; Sakalar, Teoman; Menekse, Serkan; Kut, Engin; Bilgin, Burak; Karaoglanoglu, Muge; Sunar, Veli; Ozdemir, Ozlem; Turhal, Nazim Serdar; Karadurmus, Nuri; Yalcin, Bulent; Sendur, Mehmet Ali Nahit
err分享
err收藏
Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study晚期ALK阳性非小细胞肺癌患者一线阿来替尼治疗疗效和安全性的真实数据: 土耳其肿瘤学组研究
errFUTURE ONCOLOGY
IF2.6
err2022-06-23
err1
PREAI
errHizal, Mutlu; Bilgin, Burak; Paksoy, Nail; Kilickap, Saadettin; Atci, Muhammed Mustafa; Kahraman, Seda; Keskinkilic, Merve; Bilgetekin, Irem; Ayhan, Murat; Tural, Deniz; Eren, Onder; Akkoc Mustafayev, Fatma Nihan; Yaman, Sebnem; Tatli, Ali Murat; Bayram, Ertugrul; Kutlu, Yasin; Erturk, Ismail; Ozcan, Erkan; Gulmez, Ahmet; Korkmaz, Mustafa; Akagunduz, Baran; Erdem, Dilek; Telli, Tugba Akin; Aksoy, Asude; Uskent, Necdet; Iriagac, Yakup; Baytemur, Naziyet Kose; Aydin, Dincer; Sakalar, Teoman; Arak, Haci; Selcukbiricik, Fatih; Ergun, Yakup; Korkmaz, Taner; Ak, Naziye; Unal, Caglar; Akdeniz, Nadiye; Ozgun, Mehmet Alpaslan; Oksuzoglu, Berna; Yalcin, Bulent; Oztop, Ilhan; Algin, Efnan; Sakin, Abdullah; Aydiner, Adnan; Yumuk, Perran Fulden; Nahit Sendur, Mehmet Ali
err分享
err收藏
An update on immunotherapy options for urothelial cancer尿路上皮癌免疫治疗方案的更新
errEXPERT OPINION ON BIOLOGICAL THERAPY
IF4
err2019-09-17
err13
PREAI
errBilgin, Burak; Sendur, Mehmet A. N.; Hizal, Mutlu; Yalcin, Bulent
err分享
err收藏
Do tyrosine kinase inhibitors lose favor in treatment of first-line metastatic renal cell carcinoma?
errFUTURE ONCOLOGY
IF2.6
err2019-03-11
err0
errOAAI
errYaman, Samet; Bilgin, Burak; Sendur, Mehmet A. N.; Hizal, Mutlu; Akinci, Muhammed Bulent; Yalcin, Bulent
err分享
err收藏
Optimal regimen for treatment-naive hormone receptor-positive HER-2 negative metastatic breast cancer
errFUTURE ONCOLOGY
IF2.6
err2018-11-28
err0
errOAAI
errBilgin, Burak; Sendur, Mehmet A. N.; Hizal, Mutlu; Akinci, Muhammed Bulent; Dede, Didem Sener; Yalcin, Bulent
err分享
err收藏
The current status of adjuvant treatment for high-risk renal cell carcinoma
errFUTURE ONCOLOGY
IF2.6
err2017-10-06
err0
PREAI
errHizal, Mutlu; Sendur, Mehmet A. N.; Bilgin, Burak; Akinci, Muhammed Bulent; Dede, Didem Sener; Yalcin, Bulent
err分享
err收藏
Do all aromatase inhibitors have similar efficacy and safety?
errFUTURE ONCOLOGY
IF2.6
err2017-08-23
err1
errOAAI
errSendur, Mehmet A. N.; Bilgin, Burak; Hizal, Mutlu; Ozemir, Nuriye Yildirim; Akinci, Muhammed Bulent; Dede, Didem Sener; Yalcin, Bulent
err分享
err收藏
Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer多西他赛或阿比曲酮在雄激素剥夺治疗转移性去势敏感性前列腺癌中的应用
errFUTURE ONCOLOGY
IF2.6
err2017-08-22
err2
PREAI
errBilgin, Burak; Sendur, Mehmet A. N.; Hizal, Mutlu; Akinci, Muhammed Bulent; Dede, Didem Sener; Yalcin, Bulent
err分享
err收藏
Effect of using different antihypertensive drugs on demographic and clinico-pathological characteristics of breast cancer不同降压药物对乳腺癌患者人口学及临床病理特征的影响
errANNALS OF ONCOLOGY
IF65.4
err2016-10-01
err0
errOAAI
errSendur, M. A.; Aksoy, S.; Ozdemir, N.; Yazici, O.; Akinci, M. B.; Dede, D. S.; Yalcin, B.; Zengin, N.; Altundag, K.
err分享
err收藏
Efficacy of statin usage before diagnosis on clinico-pathological characteristics and outcome of invasive breast cancer诊断前使用他汀类药物对浸润性乳腺癌临床病理特征和预后的影响
errANNALS OF ONCOLOGY
IF65.4
err2016-10-01
err0
errOAAI
errSendur, M. A.; Aksoy, S.; Ozdemir, N.; Yazici, O.; Yalcin, B.; Zengin, N.; Altundag, K.
err分享
err收藏
Effect of using different antidiabetic drugs on demographic and clinico-pathological characteristics of breast cancer不同降糖药物对乳腺癌人口统计学和临床病理特征的影响
errANNALS OF ONCOLOGY
IF65.4
err2016-10-01
err0
errOAAI
errSendur, M. A.; Aksoy, S.; Yazici, O.; Ozdemir, N.; Dede, D. S.; Akinci, M. B.; Yalcin, B.; Zengin, N.; Altundag, K.
err分享
err收藏
Selective internal radiation therapy in untreated patients with unresectable liver dominant metastatic colorectal cancer未经治疗的无法切除的肝占优势的转移性结直肠癌患者的选择性内部放射治疗
errFUTURE ONCOLOGY
IF2.6
err2016-09-20
err0
PREAI
errSendur, Mehmet A. N.; Bilgin, Burak; Akinci, Muhammed B.; Dede, Didem Sener; Ozdemir, Nuriye; Ulas, Arife; Zengin, Nurullah; Yalcin, Bulent
err分享
err收藏
The efficacy and predictive factors of response of second line triplet (modified-EOX; epirubicin-oxaliplatin-capacitabine) regimen in metastatic gastric cancer
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2015-09-01
err0
PREAI
errSendur, M. A. N.; Ozdemir, N.; Aksoy, S.; Yazici, O.; Yazilitas, D.; Akinci, M. B.; Dede, D. S.; Yalcin, B.; Zengin, N.
err分享
err收藏
Actual benefit of chemo-hormonal therapy in non-castrate metastatic prostate cancer非去势转移性前列腺癌中化学激素治疗的实际益处
errFUTURE ONCOLOGY
IF2.6
err2015-04-02
err0
PREAI
errSendur, Mehmet A. N.; Akinci, Muhammed Bulent; Ozdemir, Nuriye Yildirim; Aksoy, Sercan; Dede, Didem S.; Ulas, Arife; Zengin, Nurullah; Yalcin, Bulent
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
R
R. Shane Tubbs
H 指数: 82 · 论文数: 2.5K
M
Marios Loukas
H 指数: 73 · 论文数: 1.1K
A
Ayten Cangır
H 指数: 55 · 论文数: 244
B
Bekir Çakır
H 指数: 38 · 论文数: 675
K
Kadri Altundağ
H 指数: 37 · 论文数: 829
查看更多